PLECTIN-TARGETED LIPOSOMES/PARP INHIBITOR IN THE TREATMENT OF CANCER Application WO-2019168921-A1 World Intellectual Property Organisation (WIPO) 06 Sep 2019
Predicting tumor response to anti-ERBB3 antibodies Grant US-9828635-B2 United States of America 28 Nov 2017